Select your products and services :
Select your country :
Americas
Europe
Asia and South Pacific
Middle East and Africa

Update your choices | BU : Life Science | Country : USA

Growth Factors Related Peptides

Catalog Go™ peptides

The cellular location of Basic Fibroblast Growth Factor (bFGF) changes during development, suggesting the multiple and evolving roles it plays. bFGF participates in the process of wound healing, tissue repair, in the survival, proliferation and differentiation of immature neural cells. It has mitogenic and angiogenic properties and is actively involved in inflammatory bowel disease processes. bFGF and its receptors are expressed by granulosa cells (GCs) of healthy follicles at all stages of development. bFGF prevents GC apoptosis. It regulates intracellular free calcium through a PKC-dependent mechanism. De-regulation of bFGF expression leads to a number of pathological conditions involving angiogenesis, vascular smooth muscle cell proliferation and solid tumor growth.


DescriptionSize Reference USD Qty  
bFGF (119-126), Basic Fibroblast Growth Factor, human, mouse, rat, rabbit, bovine - 1 mg1 mg AS-61070 77.00Add to cart
VEGFR2/KDR Antagonist - 1 mg1 mg AS-60628 127.00Add to cart
Reference Name Sequence MM (kDa)
AS-61069 bFGF Inhibitory Peptide APSGHYKG 815,9
AS-61070 bFGF (119-126), human, bovine KRTGQYKL 993,2
AS-61071 bFGF Inhibitory Peptide II MWYRPDLDERKQQKRE 2178,5
AS-64142 Brain Derived Acidic FGF (101-111), bovine HAEKHWFVGL 1223,4
AS-63754 EGFR-1148,  EGFR (1140-1152) QISLDNPDYQQDF 1582,7
AS-64678 FGFR Peptide Substrate KEAPEDLYKDFLTL 1681,9
AS-62418 IGFBP6, mouse GPSEETTK 847,9
AS-62417 IGFBP6, human APAVAEENPK 1025,1
AS-62989 Gelsolin (135-142) KSGLKYKK 951,2
AS-62518 Link N DHLSDNYTLDHDRAIH 1922
AS-62192 PDGF-BB peptide CSRNLIDC (S-S BONDED) 921,1
AS-62013 EGFR (662-681) RRELVEPLTPSGEAPNQALLR 2346,7
AS-61368 Anti-Flt1 Peptide GNQWFI 763,9
AS-65288 [Glu395]-FGFR3 (371-401) RRAGSVYAGILSYGVGFFLFILVVEAVTLCRLR 3647,7
AS-65102 VEGF-A165 (310-317) CRCDKPRR 1033,3
AS-62090 VEGFR-2/ KDR I, murine FSNSTNDILI 1123,2
AS-62091 VEGFR-2/ KDR II, murine VILTNPISM 987,2
AS-60628 VEGFR-2/ KDR Antagonist ATWLPPR 840
AS-64677 FGFR, biotin-labeled Biotin-LC-KEAPEDLYKDFLTL 2021,4
AS-65405 VEGF Inhibitor Peptide; F56 WHSDMEWWYLLG 1622.8
Reference Name Description
AS-61069 bFGF Inhibitory Peptide This peptide specifically blocks the binding of bFGF-induced proliferation of vascular endothelial cells.
AS-61070 bFGF (119-126), human, bovine This peptide corresponds to human, bovine (119-126), mouse, rat (118-125) and Heparin-Binding Growth Factor 2 (118-125) residues of bFGF. It inhibits dimerization and activation of bFGF receptors.
AS-61071 bFGF Inhibitory Peptide II FGF-2 is an autocrine growth factor in the autonomous proliferation of glioma cells. This 16-residue peptide has conformational similarity to the putative receptor-binding domain of FGF-2. It suppresses growth of human glioma cells and is a potential new treatment product for malignant glioma.
AS-64142 Brain Derived Acidic FGF (101-111), bovine This peptide is isolated from bovine brain. It is bovine acidic fibroblast growth factor (FGF) amino acid residues 102 to 111.
AS-63754 EGFR-1148,  EGFR (1140-1152) This EGFR fragment contains the phosphorylation site at Tyr1148. The phosphotyrosine binding (PTB) or phosphotyrosine interaction (PI) domain of the proto-oncoprotein p52SHC binds to the NPXY consensus sequence found in several growth factor receptors. The p52SHC NH2-terminal PTB/PI domain phosphotyrosine recognition motif binds with high affinity to the autophosphorylation Tyr1148 of the EGFR.
AS-64678 FGFR Peptide Substrate This is a substrate peptide for FGFR, derived from KDR (VEGFR-2) amino acids 990 to 1002, with an additional N-terminal Lys.  FGFR is involved in cell migration, proliferation, differentiation, and survival. 
AS-62418 IGFBP6, mouse This octapeptide belongs to the mouse IGF binding protein 6 (IGFBP6). There are 6 well-characterized IGFBPs. They are not only carriers of IGFs, but also modulators of their activity. IGFBPs are also important in cell growth.
AS-62417 IGFBP6, human This decapeptide belongs to the human IGF binding protein 6 (IGFBP6). There are six well-characterized IGFBPs. These are not only carriers of IGFs, but also modulators of their activity. IGFBPs are important in cell growth.
AS-62989 Gelsolin (135-142) EGFR-mediated cell-motility is actuated partly by mobilization of membrane-associated gelsolin. The intracellular level of gelsolin is associated with cell motility.
AS-62518 Link N This peptide is cleaved from the N-terminus of the link protein component of cartilage proteoglycan A by stromelysins 1 and 2, gelatinase A, B, and collagenase. It aggregates by the action of stromelysin. This peptide can act as a growth factor and stimulate synthesis of proteoglycans and collagen in articular cartilage.
AS-62192 PDGF-BB peptide PDGF-BB peptide fragment was used in the stellate cells research. PDGF is a dimeric peptide composed of two closely related, but not identical chains, A and B, which are linked by disulfide bonds. PDGF regulates its biological functions through its binding to specific high-affinity receptors on cell surface. The PDGF alpha-receptor binds PDGF-AA and PDGF-BB, whereas the Beta-receptor (PDGFR-beta) binds PDGF-BB only. PDGF is one of the growth factors that regulates cell growth and division.
AS-62013 EGFR (662-681) This peptide was used in several assays, including determination of the p42/44 (ERK) MAP kinases activity.
AS-61368 Anti-Flt1 Peptide This short peptide binds to VEGFR1 and prevents binding of VEGF, placental growth factor (PlGF), and VEGF/PlGF heterodimer to VEGFR1. It blocks VEGF-induced migration of endothelial cells. Growth and metastasis of VEGF-secreting tumor cells are also significantly inhibited by injections of anti-Flt1 peptide. 
AS-65288 [Glu395]-FGFR3 (371-401) This peptide represents the transmembrane domain of FGFR-3 with mutation of Ala395 to Glu. FGFR3 is a member of the receptor tyrosine kinase family, proteins that activate intracellular signaling pathways upon dimerization in the plasma membrane, which functions in human skeletal development. This Ala396Glu mutant is associated with Crouzon syndrome, an autosomal dominant disorder characterized by facial bone alterations, and acanthosis nigricans, a skin disorder caused by inadequate FGFR stimulation in keratinocytes and fibroblasts.
AS-65102 VEGF-A165 (310-317) This is the C-terminal peptide of VEGF-A165. VEGF-A165 interacts with neurophilin-1 (NRP-1) to promote angiogenesis, vascular permeability, and the formation of the nervous system. This peptide has the ability to induce cell internalization and tissue penetration. The C-terminal arginine is crucial to the NRP-1-binding activity of this peptide.
AS-62090 VEGFR-2/ KDR I, murine This peptide is the murine VEGFR-2/ KDR fragment I that binds murine MHC Class I molecules and elicits an anti-angiogenic immune response. It is an angiogenesis inhibitor. VEGFR2/KDR plays a crucial role in tumor-associated angiogenesis and vascularization. Immunization with this peptide effectively reduces angiogenesis and inhibits tumor growth in mouse models. 
AS-62091 VEGFR-2/ KDR II, murine This peptide is a naturally processed CD8 T-cell epitope, the murine VEGFR-2/ KDR fragment II, that binds murine MHC Class I molecules and elicits an anti-angiogenic immune response. VEGFR2/KDR plays a crucial role in tumor-associated angiogenesis and vascularization. Immunization with this peptide effectively reduces angiogenesis and inhibits tumor growth in mouse models. 
AS-60628 VEGFR-2/ KDR Antagonist This peptide is a specific VEGFR2/KDR heptapeptide antagonist, it binds VEGFR2 (KDR/flk), completely inhibiting VEGF binding to KDR and preventing VEGF-induced angiogenesis in vivo. It specifically inhibits human endothelial cell proliferation in vitro and totally abolishes VEGF-induced angiogenesis in vivo.
AS-64677 FGFR, biotin-labeled This is a substrate peptide for FGFR, derived from KDR (vascular endothelial growth factor receptor 2) amino acids 990 to 1002, with an additional N-terminal Lys. Biotin is linked to the N-terminus through a 6-carbon linker (LC). FGFR is involved in cell migration, proliferation, differentiation, and survival.
AS-65405 VEGF Inhibitor Peptide; F56 Peptide F56 is a Flt-1 receptor antagonist that binds vascular endothelial growth factor (VEGF) in vitro and displays antiangiogenic and antimetastatic effects in vivo. This peptide may also have antitumor therapy potential. The VEGF-Flt1 interaction is important in angiogenesis in tumors, atherosclerosis and arthritis conditions.
The EGT Ordering System (EOS) is the simplest and easiest way to place your orders including:

 
All oligonucleotides
All Kits & Reagents (including Catalogue Antibodies & Peptides, Real-Time qPCR Mixes, Taq Polymerases, Sensolyte® Assays...)

Please use your Login or Register Now to directly access your customized EOS interface.



You can still place orders by:
orders.anaspec@egt-biotech.com
  When placing your order, please include the following information:
  Contact person purchase order number
  delivery address product description and reference number
  invoice address quotation number
  telephone number  

Related products


We use cookies to ensure the best experience on our website. By continuing to use this website, you consent to our cookie policy.